Sms Pharmaceuticals has informed that the Trading Window for dealing in shares of the Company for all designated persons and their immediate relatives shall remain closed from 01st January, 2025 till 48 hours after the declaration of financial results for the Third quarter ended 31st December, 2024. The date of Board Meeting for the consideration of financial results of the Company for the third quarter ended 31st December, 2024 shall be intimated in due course of time.
The above information is a part of company’s filings submitted to BSE.
